Posted by Michael Wonder on 03 Dec 2018
Recognition where it’s due: the Access to Medicines Index and the pharma industry
3 December 2018 - Former CEO of Medicines Australia Brendan Shaw says Bill Gates is correct when he says pharmaceutical companies need to get the credit when they do more for neglected diseases.
The 2018 Access to Medicines Index recently released by the Access to Medicines Foundation provides an opportunity to see where the pharmaceutical industry is working to improve access to medicines for the poor people of the world.
The report, conducted every two years, measures how the top 20 global pharmaceutical companies are improving access to medicines in seven areas: management, compliance, R&D, pricing, patents, capacity and donations.
